Literature DB >> 1698026

Smooth muscle differentiation in scleroderma fibroblastic cells.

A P Sappino1, I Masouyé, J H Saurat, G Gabbiani.   

Abstract

Using antibodies to alpha-smooth muscle actin and desmin on paraffin-embedded formalin-fixed tissue sections, the authors demonstrate that fibroblastic cells of localized and systemic scleroderma lesions express features of smooth muscle differentiation. Eleven of eleven skin specimens of systemic sclerosis patients and two of four skin specimens of localized scleroderma displayed the presence of fibroblasts expressing alpha-smooth muscle actin, a cell population that predominated in areas of prominent collagen deposition. A similar fibroblastic phenotype was found in the esophagus, the liver, and the lung specimens obtained from four patients who died of progressive systemic sclerosis. Immunostaining for desmin, performed on adjacent tissue sections, demonstrated that a minority of these fibroblastic cells present in skin and visceral lesions contained this protein. The authors' observations indicate that scleroderma fibroblasts are phenotypically related to the stromal cells previously identified in hypertrophic scars, fibromatoses, and desmoplasia; they might provide novel criteria for the characterization of scleroderma lesions and help to identify the factors responsible for phenotypic modulations in fibroblastic cells.

Entities:  

Mesh:

Year:  1990        PMID: 1698026      PMCID: PMC1877526     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels.

Authors:  J Rosenbloom; G Feldman; B Freundlich; S A Jimenez
Journal:  Arthritis Rheum       Date:  1986-07

2.  Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines.

Authors:  R Peres; C Betsholtz; B Westermark; C H Heldin
Journal:  Cancer Res       Date:  1987-07-01       Impact factor: 12.701

3.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

4.  Immunostaining of intermediate filament proteins in paraffin sections. Evaluation of optimal protease treatment to improve the immunoreactivity.

Authors:  M Miettinen
Journal:  Pathol Res Pract       Date:  1989-04       Impact factor: 3.250

Review 5.  Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).

Authors:  R B Buckingham; R K Prince; G P Rodnan; F Taylor
Journal:  J Lab Clin Med       Date:  1978-07

6.  Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis.

Authors:  V Falanga; S L Tiegs; S P Alstadt; A B Roberts; M B Sporn
Journal:  J Invest Dermatol       Date:  1987-07       Impact factor: 8.551

7.  Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.

Authors:  A P Sappino; O Skalli; B Jackson; W Schürch; G Gabbiani
Journal:  Int J Cancer       Date:  1988-05-15       Impact factor: 7.396

8.  Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.

Authors:  M R Duncan; B Berman
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

Review 9.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.

Authors:  G K Hansson; M Hellstrand; L Rymo; L Rubbia; G Gabbiani
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  25 in total

1.  Remodeling of the actin cytoskeleton in the contracting A7r5 smooth muscle cell.

Authors:  M E Fultz; C Li; W Geng; G L Wright
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

2.  Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.

Authors:  Yavuz Pehlivan; Servet Yolbas; Gozde Yıldırım Cetin; Fatma Alibaz-Oner; Yonca Cagatay; Neslihan Yilmaz; Serdar Oztuzcu; Salim Donmez; Metin Ozgen; Suleyman Serdar Koca; Omer Nuri Pamuk; Mehmet Sayarlıoglu; Bunyamin Kisacik; Haner Direskeneli; Abdullah Tuncay Demiryurek; Ahmet Mesut Onat
Journal:  Rheumatol Int       Date:  2015-11-28       Impact factor: 2.631

3.  An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.

Authors:  Flavia V Castelino; Gretchen Bain; Veronica A Pace; Katharine E Black; Leaya George; Clemens K Probst; Lance Goulet; Robert Lafyatis; Andrew M Tager
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

4.  Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts.

Authors:  Xiuxia Zhou; Wei Wu; Haizhen Hu; Jadranka Milosevic; Kazuhisa Konishi; Naftali Kaminski; Sally E Wenzel
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

5.  Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis.

Authors:  Remedios Castello-Cros; Diana Whitaker-Menezes; Alex Molchansky; George Purkins; Louis J Soslowsky; David P Beason; Federica Sotgia; Renato V Iozzo; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

Review 6.  The versatility of microvascular pericytes: from mesenchyme to smooth muscle?

Authors:  V Nehls; D Drenckhahn
Journal:  Histochemistry       Date:  1993-01

Review 7.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Authors:  A Schmitt-Gräff; A Desmoulière; G Gabbiani
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.

Authors:  M Tokunou; T Niki; K Eguchi; S Iba; H Tsuda; T Yamada; Y Matsuno; H Kondo; Y Saitoh; H Imamura; S Hirohashi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

9.  The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

Authors:  Yoshihito Shima; Yusuke Kuwahara; Hiroyuki Murota; Shun Kitaba; Mari Kawai; Toru Hirano; Junsuke Arimitsu; Masashi Narazaki; Keisuke Hagihara; Atsushi Ogata; Ichiro Katayama; Ichiro Kawase; Tadamitsu Kishimoto; Toshio Tanaka
Journal:  Rheumatology (Oxford)       Date:  2010-09-05       Impact factor: 7.580

10.  Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

Authors:  Laura Koumas; Terry J Smith; Steven Feldon; Neil Blumberg; Richard P Phipps
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.